(Q37819144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Paul Proost

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Anneleen Mortier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mieke Gouwy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

10 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

642-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokines: a new classification system and their role in immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The evolution of mammalian chemokine genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Macrophage inflammatory protein-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The MCP/eotaxin subfamily of CC chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

A new class of membrane-bound chemokine with a CX3C motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Lymphotactin: a cytokine that represents a new class of chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CXC chemokines in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Viral exploitation and subversion of the immune system through chemokine mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Involvement of chemokine receptors in breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Therapeutic targeting of chemokine interactions in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Anti-chemokine small molecule drugs: a promising future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Synergy in cytokine and chemokine networks amplifies the inflammatory response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokine patterning by glycosaminoglycans and interceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Tuning inflammation and immunity by chemokine sequestration: decoys and more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Identification and characterization of PF4varl, a human gene variant of platelet factor 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Contribution of Duffy antigen to chemokine function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Regulation of chemokine activity by posttranslational modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Initial characterization of the carbohydrate structure of MCP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Identification of interleukin-8 converting enzyme as cathepsin L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Streptococcus agalactiae CspA is a serine protease that inactivates chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokines in hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Modulation of hematopoietic stem cell homing and engraftment by CD26

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Echinococcus multilocularis metacestode metabolites contain a cysteine protease that digests eotaxin, a CC pro-inflammatory chemokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Proteolytic activation of alternative CCR1 ligands in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokines take centre stage in vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Increased serum CXCL16 level is a marker for acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Distinct role of the intracellular C-terminus for subcellular expression, shedding and function of the murine transmembrane chemokine CX3CL1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Fractalkine and fractalkine receptors in human neurons and glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

High level expression of human MCP-1 using the LCR/MEL expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Production and identification of natural monocyte chemotactic protein from virally infected murine fibroblasts. Relationship with the product of the mouse competence (JE) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Intrapersonal and populational heterogeneity of the chemokine RANTES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Posttranslationally processed forms of the human chemokine HCC-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Purification, structural analysis, and function of natural ATAC, a cytokine secreted by CD8(+) T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Glycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. Role of the transmembrane domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Expression and targeting of CX3CL1 (fractalkine) in renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Antibodies to citrullinated proteins: molecular interactions and arthritogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.11.016

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation

7 January 2021

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-08-0482

Identifiers

DOI

10.1016/J.YEXCR.2010.11.016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21146523%20AND%20SRC:MED&resulttype=core&format=json

release_mbun5p3hlbg2dncphpjdm6qnwu

17 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mbun5p3hlbg2dncphpjdm6qnwu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference